E-viri
Recenzirano
Odprti dostop
-
Potluri, Vishnu S.; Bloom, Roy D.
Kidney international, July 2018, 2018-07-00, 20180701, Letnik: 94, Številka: 1Journal Article
In this issue, Alric and colleagues demonstrate through real-world experience that grazoprevir-elbasvir is safe and effective for treating hepatitis C in advanced kidney disease patients with higher comorbidity burdens. This commentary highlights that this and similar studies have primarily focused on treatment safety and efficacy, rather than the clinical impact of viral eradication. Critical knowledge gaps including which patients to treat, and when, as well as potential management strategies that may improve outcomes, are discussed.
